![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MIR210HG |
Gene summary for MIR210HG |
![]() |
Gene information | Species | Human | Gene symbol | MIR210HG | Gene ID | 100506211 |
Gene name | MIR210 host gene | |
Gene Alias | MIR210HG | |
Cytomap | 11p15.5 | |
Gene Type | ncRNA | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
100506211 | MIR210HG | HCC1_Meng | Human | Liver | HCC | 5.04e-32 | 6.62e-02 | 0.0246 |
100506211 | MIR210HG | HCC1 | Human | Liver | HCC | 3.79e-03 | 8.69e-01 | 0.5336 |
100506211 | MIR210HG | HCC2 | Human | Liver | HCC | 2.45e-17 | 3.03e+00 | 0.5341 |
100506211 | MIR210HG | S015 | Human | Liver | HCC | 3.30e-03 | 3.16e-01 | 0.2375 |
100506211 | MIR210HG | S029 | Human | Liver | HCC | 6.19e-07 | 3.84e-01 | 0.2581 |
100506211 | MIR210HG | C21 | Human | Oral cavity | OSCC | 5.82e-10 | 4.58e-01 | 0.2678 |
100506211 | MIR210HG | C43 | Human | Oral cavity | OSCC | 2.78e-23 | 4.89e-01 | 0.1704 |
100506211 | MIR210HG | C51 | Human | Oral cavity | OSCC | 6.87e-11 | 6.22e-01 | 0.2674 |
100506211 | MIR210HG | C08 | Human | Oral cavity | OSCC | 2.72e-07 | 2.02e-01 | 0.1919 |
100506211 | MIR210HG | SYSMH1 | Human | Oral cavity | OSCC | 1.37e-33 | 7.44e-01 | 0.1127 |
100506211 | MIR210HG | ATC09 | Human | Thyroid | ATC | 1.54e-16 | 5.67e-01 | 0.2871 |
100506211 | MIR210HG | ATC12 | Human | Thyroid | ATC | 1.19e-10 | 2.45e-01 | 0.34 |
100506211 | MIR210HG | ATC13 | Human | Thyroid | ATC | 1.15e-03 | 1.12e-01 | 0.34 |
100506211 | MIR210HG | ATC1 | Human | Thyroid | ATC | 1.41e-18 | 6.48e-01 | 0.2878 |
100506211 | MIR210HG | ATC4 | Human | Thyroid | ATC | 8.48e-13 | 3.05e-01 | 0.34 |
100506211 | MIR210HG | ATC5 | Human | Thyroid | ATC | 5.14e-03 | 1.15e-01 | 0.34 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Stomach | WIM | ![]() |
Stomach | SIM | ![]() |
Liver | NAFLD | ![]() |
Liver | Cirrhotic | ![]() |
Liver | HCC | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |